View Cart  

FDA Extends PDUFA Date for Biogen’s MS Treatment BG-12 to Late March

A A
The FDA has extended the PDUFA date for Biogen Idec’s multiple sclerosis (MS) treatment BG-12 by three months to March 28, 2013.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00